Cannabinoids, Synthetic

Synthetic cannabinoids are developed by people drugs that tetrahydrocannabinol (THC) are receptor agonists. They are usually used on dried plant material and smoked.

THC is the major active ingredient in marijuana (cannabis). There are many chemical families of synthetic cannabinoids, including HU-210, JWH-073, JWH-018, JWH-200, AM-2201, UR-144 and XLR-11; new connections are regularly reported.

Synthetic cannabinoids are developed by people drugs that tetrahydrocannabinol (THC) are receptor agonists. They are usually used on dried plant material and smoked. THC is the major active ingredient in marijuana (cannabis). There are many chemical families of synthetic cannabinoids, including HU-210, JWH-073, JWH-018, JWH-200, AM-2201, UR-144 and XLR-11; new connections are regularly reported. Effects vary widely depending on the specific cannabinoid, and many of the acute and chronic effects remain unknown. However, the stimulation of the THC receptor causes an altered mental status with agitation, hallucinations and psychosis (which may be irreversible). Among the cardiovascular effects include hypertension, tachycardia and heart attack. The neurological effects include seizures and blurred vision. Other known effects include vomiting, hyperthermia, rhabdomyolysis and renal failure. Symptoms and discomfort patients can cause severe agitation, hallucinations, tachycardia, hypertension, sweating and seizures have. Diagnosis Clinical Investigation Synthetic cannabinoids are not detected during routine urine tests. In patients with severe acute poisoning should generally blood tests (CBC, electrolytes, BUN, creatinine, CK), urine tests for myoglobinuria and ECG should be performed. Therapy Intravenous sedation with benzodiazepines sedation with iv Benzodiazepines, infusions and supportive care are usually sufficient. Patients with hyperthermia, persistent tachycardia or restlessness, and increased serum creatinine should be monitored for rhabdomyolysis and cardiac and kidney damage.

Health Life Media Team

Leave a Reply